Evidence map›Paper›PMID 32274568›Full record

ArticleHuman genetics2020

CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix.

Juan-Manuel Bonet-Fernández, José-Daniel Aroca-Aguilar, Marta Corton, Ana-Isabel Ramírez, Susana Alexandre-Moreno, María-Teresa García-Antón, Juan-José Salazar, Jesús-José Ferre-Fernández, Raquel Atienzar-Aroca, Cristina Villaverde and 10 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Genetic Analysis ofBiomedicines · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Genetic Aspects of Glaucoma: An Updated Review.Current molecular medicine · 2024
    Review
  16. Article
  17. Article
  18. Compound Heterozygous Variants of theFrontiers in genetics · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Juan-Manuel Bonet-FernándezÁrea de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
José-Daniel Aroca-AguilarÁrea de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Marta CortonÁrea de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Ana-Isabel RamírezCooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Susana Alexandre-MorenoÁrea de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
María-Teresa García-AntónInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain.
Juan-José SalazarCooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Jesús-José Ferre-FernándezÁrea de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Raquel Atienzar-ArocaÁrea de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Cristina VillaverdeÁrea de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Ionut IancuÁrea de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Alejandra TamayoÁrea de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Carmen-Dora Méndez-HernándezCooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Laura Morales-FernándezCooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Blanca RojasCooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Carmen AyusoÁrea de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Miguel Coca-PradosDepartment of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA.
José-Maria Martinez-de-la-CasaCooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Julián García-FeijooCooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Julio EscribanoÁrea de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain. julio.escribano@uclm.es.ORCID http://orcid.org/0000-0002-8919-8134
Instituto de Salud Carlos III · ESCentre for Biomedical Network Research on Rare Diseases · ESUniversidad Complutense de Madrid · ESHospital Universitario Fundación Jiménez Díaz · ESYale University · US

Funding

Consejería de educacion de Castilla-La Mancha SBPLY/17/180501/000404Instituto de Salud Carlos III CIBERER 06/07/0036Instituto de Salud Carlos III PI15/01193, PI19/00208 and RD16/0008/0019, OFTAREDInstituto de Salud Carlos III PI17_01164Instituto de Salud Carlos III RD16/0008/0004, OFTAREDInstituto de Salud Carlos III RD16/0008/0005, OFTAREDMinisterio de Economía y Competitividad SAF2013-46943Ramon Areces Foundation and Regional Government of Madrid CAM, B2017/BMD3721
6 · The paper itself

Abstract

Abnormal development of the ocular anterior segment may lead to a spectrum of clinical phenotypes ranging from primary congenital glaucoma (PCG) to variable anterior segment dysgenesis (ASD). The main objective of this study was to identify the genetic alterations underlying recessive congenital glaucoma with ASD (CG-ASD). Next-generation DNA sequencing identified rare biallelic CPAMD8 variants in four patients with CG-ASD and in one case with PCG. CPAMD8 is a gene of unknown function and recently associated with ASD. Bioinformatic and in vitro functional evaluation of the variants using quantitative reverse transcription PCR and minigene analysis supported a loss-of-function pathogenic mechanism. Optical and electron microscopy of the trabeculectomy specimen from one of the CG-ASD cases revealed an abnormal anterior chamber angle, with altered extracellular matrix, and apoptotic trabecular meshwork cells. The CPAMD8 protein was immunodetected in adult human ocular fluids and anterior segment tissues involved in glaucoma and ASD (i.e., aqueous humor, non-pigmented ciliary epithelium, and iris muscles), as well as in periocular mesenchyme-like cells of zebrafish embryos. CRISPR/Cas9 disruption of this gene in F0 zebrafish embryos (96 hpf) resulted in varying degrees of gross developmental abnormalities, including microphthalmia, pharyngeal maldevelopment, and pericardial and periocular edemas. Optical and electron microscopy examination of these embryos showed iridocorneal angle hypoplasia (characterized by altered iris stroma cells, reduced anterior chamber, and collagen disorganized corneal stroma extracellular matrix), recapitulating some patients' features. Our data support the notion that CPAMD8 loss-of-function underlies a spectrum of recessive CG-ASD phenotypes associated with extracellular matrix disorganization and provide new insights into the normal and disease roles of this gene.

Indexed as

Loss of Function MutationAdultalpha-MacroglobulinsAnimalsAnterior ChamberCase-Control StudiesComplement C3CRISPR-Cas SystemsEmbryo, NonmammalianExtracellular MatrixEye AbnormalitiesFemaleGene EditingGene ExpressionGenes, RecessiveGlaucomaalpha-MacroglobulinsComplement C3CPAMD8 protein, humanTrypsin Inhibitor, Kazal Pancreatic

Identifiers

PMID32274568
OpenAlexW3015988719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.